BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25380191)

  • 1. Aspirin and NSAIDs for breast cancer chemoprevention.
    Yiannakopoulou ECh
    Eur J Cancer Prev; 2015 Sep; 24(5):416-21. PubMed ID: 25380191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.
    Clarke CA; Canchola AJ; Moy LM; Neuhausen SL; Chung NT; Lacey JV; Bernstein L
    Breast Cancer Res; 2017 May; 19(1):52. PubMed ID: 28460643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and NSAIDs: effects in breast and ovarian cancers.
    Crew KD; Neugut AI
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):71-5. PubMed ID: 16493264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells.
    Adachi M; Sakamoto H; Kawamura R; Wang W; Imai K; Shinomura Y
    Histol Histopathol; 2007 Apr; 22(4):437-42. PubMed ID: 17290354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Salicylates and the Other Nonsteroidal Anti-Inflammatory Agents With Breast Cancer Endocrine Treatment: Systematic Review.
    Ch Yiannakopoulou E
    Am J Clin Oncol; 2015 Dec; 38(6):641-4. PubMed ID: 25503435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
    Johnson TW; Anderson KE; Lazovich D; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1586-91. PubMed ID: 12496048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer.
    Rahme E; Ghosn J; Dasgupta K; Rajan R; Hudson M
    BMC Cancer; 2005 Dec; 5():159. PubMed ID: 16343343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evidence of the relationship between aspirin and breast cancer risk (review).
    Jacobo-Herrera NJ; Pérez-Plasencia C; Camacho-Zavala E; González GF; Urrutia EL; García-Castillo V; Zentella-Dehesa A
    Oncol Rep; 2014 Aug; 32(2):451. PubMed ID: 24927467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSAIDs and breast cancer: a possible prevention and treatment strategy.
    Agrawal A; Fentiman IS
    Int J Clin Pract; 2008 Mar; 62(3):444-9. PubMed ID: 18194278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk.
    Shen J; Gammon MD; Terry MB; Teitelbaum SL; Neugut AI; Santella RM
    Breast Cancer Res; 2006; 8(6):R71. PubMed ID: 17181859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAIDs and breast cancer recurrence in a prospective cohort study.
    Kwan ML; Habel LA; Slattery ML; Caan B
    Cancer Causes Control; 2007 Aug; 18(6):613-20. PubMed ID: 17404892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-steroidal anti-inflammatory drugs and chemoprevention of cancer.
    Vainio H; Morgan G
    Ann Chir Gynaecol; 2000; 89(3):173-6. PubMed ID: 11079784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence.
    Silva MT; Galvao TF; Zimmerman IR; Pereira MG; Lopes LC
    Curr Pharm Des; 2012; 18(26):4047-70. PubMed ID: 22632754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study.
    Friis S; Thomassen L; Sørensen HT; Tjønneland A; Overvad K; Cronin-Fenton DP; Vogel U; McLaughlin JK; Blot WJ; Olsen JH
    Eur J Cancer Prev; 2008 Apr; 17(2):88-96. PubMed ID: 18287865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do postoperative NSAIDs improve breast cancer outcomes? A Best Evidence Topic.
    Sutton L; McGlone E; Lambert K
    Int J Surg; 2016 Apr; 28():173-8. PubMed ID: 26926089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer.
    Schrör K
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):473-84. PubMed ID: 22122764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action.
    Husain SS; Szabo IL; Tamawski AS
    Am J Gastroenterol; 2002 Mar; 97(3):542-53. PubMed ID: 11922545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAID use and breast cancer risk in the VITAL cohort.
    Ready A; Velicer CM; McTiernan A; White E
    Breast Cancer Res Treat; 2008 Jun; 109(3):533-43. PubMed ID: 17674199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents--implications for cancer treatment and chemoprevention.
    Yiannakopoulou E
    Cell Oncol (Dordr); 2014 Jun; 37(3):167-78. PubMed ID: 24996792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-steroidal anti-inflammatory drugs in chemoprevention of breast and prostate cancer.
    Badawi AF; El-Sohemy A
    Med Hypotheses; 2001 Aug; 57(2):167-8. PubMed ID: 11461166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.